This podcast series explores the clinical features of both active and chronic thyroid eye disease, provides an in-depth discussion on current medical and surgical options for TED and emerging therapies, and examines the multidisciplinary management of thyroid eye disease, with a focus on teprotumumab-associated adverse effects. Earn up to 1.5 COPE CE Credits or 1.5 AMA PRA Category 1 Credits™.